Skip to content
healthcare.dev

CHLORZOXAZONE

NDC 16571-725, CHLORZOXAZONE, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-725
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213126
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-725 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHLORZOXAZONE375 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
16571-725-0116571072501100 TABLET in 1 BOTTLE (16571-725-01)
16571-725-5016571072550500 TABLET in 1 BOTTLE (16571-725-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1df6058b-7bf2-4246-9827-93fa023a5fd4
  • NADAC price for package 16571072501

    GET /v1/drugs/nadac/16571072501

Use it

Look up 16571-725 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-725 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-725. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.